Background:
The Oscillatoria Agardhii agglutinin homolog (OAAH) proteins constitute a novel lectin family. Results: 3D structures, carbohydrate binding specificities, and antiviral activity data for several members were determined. Conclusion: All members display potent anti-HIV activity. Significance: Our results uncovered the structural basis of protein-carbohydrate recognition in this novel lectin family and provide insights into the molecular basis of their HIV inactivation properties.
SUMMARY
Oscillatoria Agardhii agglutinin homolog (OAAH) proteins belong to a recently discovered lectin family. All members contain a sequence repeat of ~66 amino acids, with the number of repeats varying among different family members. Apart from data for the founding member OAA, neither threedimensional structures, nor information about carbohydrate binding specificities, nor antiviral activity data is available up to now for any other members of the OAAH family. In order to elucidate the structural basis for the antiviral mechanism of OAAHs, we determined the crystal structures of Pseudomonas fluorescens and Myxococcus Xanthus lectins. Both proteins exhibit the same fold, resembling the founding family member, OAA, with minor differences in loop conformations. Carbohydrate binding studies by NMR and X-ray structures of glycan-lectin complexes reveal that the number of sugar binding sites corresponds to the number of sequence repeats in each protein.
Like for OAA, tight and specific binding to α3,α6-mannopentaose was observed. All the OAAH proteins described here exhibit potent anti-HIV activity at comparable levels. Altogether, our results provide structural details of the protein-carbohydrate interaction for this novel lectin family and insights into the molecular basis of their HIV inactivation properties.
The development of carbohydrate binding proteins (lectins) as microbicidal drugs represents a novel therapeutic approach in the fight against HIV transmission (1) (2) (3) . This strategy is particularly useful for women in some regions of the world where social and psychological barriers are substantial and not easily overcome. For example, due to economic and societal pressures, diagnosis and treatment for HIV infections may not be readily available or are stigmatized. Therefore, using microbicides designed to significantly reduce transmission of sexually transmitted viral pathogens when applied topically to genital mucosal surfaces is potentially a powerful strategy, given that application in cream form is discreet and can be completely controlled by women.
One of several lectins that were selected as a candidate for lectin-based microbicides is Cyanovirin-N (CV-N) (4) (5) (6) . It exhibits potent antiviral activity by blocking virus entry into the host target cells through specific and tight binding to Manα(1-2)Man linked mannose substructures (7) (8) (9) (10) (11) (12) , in particular the D1 or D3 arms of the remarkably enriched high-mannose N-linked glycans, present on the HIV envelope glycoprotein 120 (gp120), thereby compromising the required conformational changes in gp120/gp41 for fusion with the target cell membrane. Following CV-N's discovery, there have been a growing number of lectins that are also known to bind to the high mannose glycans on gp120, such as DC-SIGN (13), a dendritic cell surface receptor that captures HIV-1 and facilitates infection of HIV-1 permissive cells in trans by endocytosis (14) , as well as a variety of cyanobacterial-or actinomycetal-derived proteins like Scytovirin (15) , Griffithsin (16) , MVL (17) , and Actinohivin (18) . Notably, the target epitopes on Man-8/9 and binding modes for these different lectins are quite distinct (7, 10, (19) (20) (21) (22) . In an effort to characterize as many possible mannose-targeting lectins structurally, as well as with respect to their recognition epitopes, we recently investigated a novel antiviral lectin from the cyanobacterium Oscillatoria Agardhii (named Oscillatoria Agardhii Agglutinin; OAA) (23, 24) . Surprisingly, the compact, β-barrel-like architecture of OAA is very different from previously characterized lectin structures and unique among all available protein structures in the protein data bank. Most importantly, so far OAA's carbohydrate recognition of Man-9 is also unique, compared to all other anti-viral lectins. While most of the known HIV-inactivating lectins recognize the reducing or non-reducing end mannoses of Man-8/9, OAA recognizes the branched core unit of Man-8/9.
Genes coding for OAA-homologous proteins have recently been discovered in a number of other prokaryotic microorganisms, including cyanobacteria, proteobacteria, and chlorobacteria, as well as in an eukaryotic marine red alga (25) . Similar to OAA, these proteins, termed OAAHs, contain a sequence repeat of ~66 amino acids, with the number of repeats varying for different family members. For example, the 133 residue containing Pseudomonas fluorescens and Herpetosiphon aurantiacus homologs contain two sequence repeats, like OAA, while Lyngbya sp., Burkholderia oklahomensis EO147, Stigmatella aurantiaca DW4/3-1, Myxococcus Xanthus, and Eucheuma serra homologs contain four sequence repeats over lengths of 246 to 268 residues (25) .
Apart from data for the founding member OAA, neither three-dimensional structures nor information about carbohydrate binding specificities nor antiviral activity is available up to now for any other member of the OAAH family. In order to further characterize this important lectin family, we carried out structural analyses of two additional members of the OAAH family. We determined the structures of the Pseudomonas fluorescens and the Myxococcus Xanthus OAAHs that contain two and four sequence repeats, respectively. We delineated the conserved sequence and structure features in these proteins and determined their sugar binding specificities by NMR titrations and X-ray crystallography. In addition, HIV assays were carried out and we observed that the antiviral potency for all OAAH family members investigated here is comparable and is not significantly enhanced when more binding sites are present. Altogether, our results provide the basis for expanding our knowledge with respect to protein-carbohydrate interaction in general and recognition of α3,α6-mannopentaose by this class of lectins in particular.
EXPERIMENTAL PROCEDURES

Protein
expression, purification, and crystallization -PFA and MBHA were expressed and purified as described previously for OAA (23) . Briefly, synthetic PFA and MBHA genes encoding residues 1−133 and 1 -267 (25) were cloned into the pET-26b(+) expression vector (Novagen), using NdeI and XhoI restriction sites at the 5' and 3' ends, respectively. E. coli Rosetta2 (DE3) cells (Novagen) were transformed with the pET-26b(+)-PFA or the pET-26B(+)-MBHA vector for protein expression. Cells were initially grown at 37 o C, induced with 1 mM IPTG, and grown for ~18 h at 16 o C for protein expression.
The hybrid OAAH protein (OPA) was created by combining the OAA and PFA genes via a six nucleotide linker encoding N-G residues, thus generating a 267 residue chimera. Individual DNA by guest on September 1, 2017
http://www.jbc.org/ Downloaded from fragments encoding residues M1 to T133 of OAA (PCR1) and residues S2 to E133 of OAA (PCR2) were amplified using the parent vectors as templates. PCR1 (amplification of OAA utilized oligonucleotides 5'-GCGAAATTAATACGACT-CACTATAGGGG-3' (T7 promoter) as forward and 5'-CCGCATATTTGCTACCGTTCGTCA-GGGTACCTTTGAAGCCGATC-3' (R1) as reverse primers. Note that the first 13 (italic), the ACCGTT (bolded), and the last 25 (underlined) nucleotides in the reverse primer (R1) are nucleotides that code for the first few N-terminal residues of PFA, the N-G linker residues, and the last few C-terminal residues of OAA. PCR2 (amplification of PFA) was performed with the oligonucleotides 5'-GGTACCCTGACGAAC-GGTAGCAAATATGCGGTGGCCAACCAGTG-3' as forward (F2) and 5'-CAAAAAACCCC-TCAAGACCCGTTTAGAG-3' (T7 terminator) as reverse primers. For PCR2, the first 12 nucleotides (underlined), the ACCGTT (bolded), and the last 26 (italic) nucleotides in the forward primer (F2) are nucleotides that encode for the last few Cterminal residues of OAA, the N-G linker residues, and the first few N-terminal residues of PFA. PCR3, as the final step was performed after mixing equal amounts of these two PCR products and amplifying with T7 promoter and T7 terminator primers, respectively. Once the complete DNA fragment encoding the full length OPA was generated, the fragment was cloned into the pET-26b(+) expression vector (Novagen), using NdeI and XhoI restriction sites at the 5' and 3' ends, respectively. E. coli Rosetta2 (DE3) cells (Novagen) were transformed with the pET-26b(+)-OPA vector for protein expression. As for PFA and MBHA, cells were initially grown at 37 o C, induced with 1 mM IPTG, and grown for ~18 h at 16 o C for protein expression.
Protein was prepared from the soluble fraction after rupturing the cells by sonication. The cell lysate was centrifuged to remove cell debris and, after centrifugation, the supernatant was dialyzed over night against 20 mM Tris-HCl buffer (pH 8.5) for OPA and against 20 mM NaAcetate buffer (pH 5.0) for PFA and MBHA. The first purification step involved anion-exchange chromatography on a Q(HP) column (GE Healthcare) for OPA and a SP(HP) column (GE Healthcare) for PFA and MBHA, using a linear gradient of NaCl (0-1000 mM) for elution. Diffraction data collection and structure determination of apo PFA, apo MBHA, and glycan-bound MBHA -X-ray diffraction data for apo PFA, apo MBHA, and glycan-bound MBHA crystals were collected up to 1.70, 1.60, and 1.76 Å resolution, respectively, on flash-cooled crystals (-180°C) using a Rigaku FR-E generator with a Saturn 944 CCD detector or a R-AXIS IV image plate detector at a wavelength corresponding to the copper edge (1.54 Å). All diffraction data were processed, integrated, and scaled using d*TREK software (26) , and eventually converted to mtz format using the CCP4 package (27) . The unit-cell dimensions of the C2 apo PFA crystal were Phases for both apo PFA and MBHA crystals were determined by molecular replacement using the previously determined structure of OAA (PDB:3S5V) (23, 24) as structural probe in PHASER (28) . After generation of the initial model, the chain was re-built using the program Coot (29) . Iterative refinement was carried out by alternating between manual re-building in Coot (29) and automated refinement in REFMAC (30) . Similar procedures were adopted for the diffraction data collected from the complex MBHA crystal. In the later case, the structure obtained from the apo MBHA protein was used as the structural probe for molecular replacement.
All final models exhibit clear electron density for all residues (2-133 and 2-267 for PFA and MBHA, respectively). Note that the first residue (M1) was completely removed by the E.coli N-terminal methionine aminopeptidase during protein expression (verified by NMR and mass spectrometry). The final apo PFA structure is well defined to 1.70 Å resolution with an R-factor of 17.6% and a free R of 21.5%. 98.9% and 100% of all residues are located in the favored and allowed regions of the Ramachandran plot, respectively, and no residues are in the disallowed region as evaluated by MOLPROBITY (31) . Similarly, the final apo MBHA structure was well defined to 1.60 Å resolution with an R-factor of 17.8% and a free R of 21.2%. 97.4% and 100% of all residues are located in the favored and allowed regions of the Ramachandran plot, respectively, and no residues are in the disallowed region as evaluated by MOLPROBITY (31) . In the MBHA-α3,α6-mannopentaose complex crystals, additional electron density was present only in the two carbohydrate binding sites of the second barrel of MBHA. The extra density in both sites permitted fitting of a α3,α6-mannopentaose molecule into each binding site. The final complex structure is well refined with an R-factor of 18.6% and a free R of 22.4%. 98.5%, and 100% of all residues lie in the favored and allowed regions of the Ramachandran plot, respectively. A summary of the data collection parameters as well as pertinent structural statistics for all structures is provided in Table 1 . All structural figures were generated with Chimera (32) or PyMOL (33) . The atomic coordinates and diffraction data for apo PFA, apo MBHA, and the α3,α6-mannopentaose-bound MBHA structures have been deposited in the RCSB Protein Data Bank under accession codes 4FBO, 4FBR, and 4FBV, respectively.
Carbohydrate
binding studies by NMR Spectroscopy -3D NMR HNCACB and CBCA(CO)NH spectra (34) were recorded for complete backbone chemical shift assignment of apo and α3,α6-mannopentaose-bound PFA at 25°C on a Bruker AVANCE800 spectrometer, equipped with a 5-mm triple-resonance, z-axis gradient cryoprobe. For apo and α3,α6-mannopentaose-bound MBHA, partial backbone chemical shift assignment were obtained using 3D NMR TROSY-HNCACB and TROSY-CBCA(CO)NH spectra on a Bruker AVANCE900 spectrometer, also equipped with a 5-mm tripleresonance, z-axis gradient cryoprobe. All protein spectra were recorded on a 13 C/ 15 N-labeled sample in 20 mM NaAcetate, 20 mM NaCl, 3 mM NaN 3 , 90/10% H 2 O/D 2 O (pH 5.0). The protein concentration (~1.0 mM) was similar in concentration to the one used for crystallization (~40 mg/mL). All spectra were processed with NMRPipe (35) and analyzed using NMRView (36) .
Binding of α3,α6-mannopentaose (Sigma Aldrich) was investigated at 25°C using 0.040 mM 15 Anti-HIV assay -HIV viral activity assays were performed using TZM-bl (37) cells cultured in Dulbecco's modified Eagle's medium containing fetal bovine serum (10%), penicillin, and streptomycin. Cells were seeded at 10,000 per well in a 96 well plate in 100 µl volumes of media 16 h before inoculation. Wild type HIV-1 (1 ng of p24 per well), produced by transfection of 293T cells with the R9 proviral clone, was used for infection. This dose of virus was selected to keep the infection below saturation, ensuring linearity in the assay. 16h after of seeding of TZM-bl cells, the medium was aspirated, and 100 µl of medium containing virus and antiviral proteins was added to the cultures, supplemented with DEAE-dextran (20 µg/ml). All samples were carried out as duplicates. Cultures were incubated for 48h at 37 0 C, after which 100 µl of Steady-Glo luciferase substrate (Promega) was added to each well. Plates were incubated at room temperature for 5 min, and luminescence was quantified by TopCount NXT TM (Packard Bioscience). The readout is relative luminescence units (RLU), which is directly proportional to infectivity. Values are expressed relative to the control cultures lacking antiviral protein. Antiviral potency was determined as the concentration of the inhibitor required for 50% inhibition of infection (IC 50 ), and was extracted manually based on the nonlinear regression algorithm produced in KaleidaGraph.
RESULTS AND DISCUSSION
Structures of OAAHs; PFA and MBHA -The amino acid sequences of the P. fluorescens and M. Xanthus lectins, designated as PFA and MBHA throughout the manuscript, possess extensive sequence similarity to OAA, with ~62 % identity for pairwise alignment ( Figure 1A) . Interestingly, the majority of the amino acid conservation resides in the carbohydrate binding regions, delineated previously in OAA ( Figure 1B ). This region encompasses the loops between β1-β2, β7-β8, and β9-β10 in the first binding site and between β6-β7, β2-β3, and β4-β5 in the second binding site. In addition, notable sequence conservation is seen throughout the secondary structure elements, with residues Y4 and V6 in β1, W17, G20, G21, and W23 in β2, V34 and A35 in β3, G49, T50, M51, T52, and Y53 in β4, I59, G60, and F61 in β5, Y71, V73, E74, N75, and Q76 in β6, W84, G87, G88, and W90 in β7, A102 in β8, L114, G116, T117, T119, and Y120 in β9, and F128 in β10 being invariant in all three sequences (all numbering refers to OAA).
PFA assembles into a single, compact, β-barrellike domain as previously observed for OAA ( Figure 1C ). Each sequence repeat folds up into five β-strands, denoted as β1 to β5 (colored in white) and β6 to β10 (colored in blue) for the first and second repeats of the first molecule in the asymmetric unit, respectively. For the second molecule in the asymmetric unit, the first and second five β-strands are colored in grey and light blue, respectively. A very short linker, comprising residues G67-N69 connects the two-sequence repeats (colored in orange) in both molecules. Note that the two individual PFA molecules in the asymmetric unit are essentially identical with root mean square deviations (r.m.s.d) for backbone and heavy atoms (residues S2 to I132) of 0.49 and 0.90 Å, respectively. Different to OAA or PFA, MBHA contains four sequence repeats and in its crystal structure each two-sequence repeat folds into a β-barrel, resulting in a tandem arrangement of two barrels ( Figure  1D ). The first barrel is composed of the first ten β-strands, colored in white and purple, and the second barrel is made up by the second ten β-strands, colored in grey and light magenta, respectively. Three short linkers comprising residues S67-N69, T133-G135, and S201-D203 connect the first and second five β-strands, the first and second barrels, and the third and fourth five β-strands, respectively. The structures of the first (residues A2 to V132) and second (residues D136 to L266) barrels of MBHA are alike, with a backbone atom r.m.s.d value of 0.63 Å. In comparing the relative orientations of the two molecules of PFA and the two tandem domains of MBHA it should be noted that they are quite different ( Figure 1C and 1D) , with an almost 180 o flip of the second molecule/domain (right side in Figure 1C and 1D) relative to the first one (left side in Figure 1C and 1D) .
Comparison of the overall structures of these new family members with that of the founding member, OAA, also revealed a close resemblance. The overall r.m.s.d values for backbone atoms between OAA (residues A2 to L132) and PFA (residues S2 to I132) is 0.50 Å (Figure 2A ), between OAA (residues A2 to L132) and the first domain of MBHA (residues A2 to V132) it is 0.79 Å ( Figure 2B ), and between OAA (residues A2 to L132) and the second domain of MBHA (residues D136 to L266) it is 0.70 Å ( Figure 2C ). Similarly, PFA is also similar to each of the MBHA domains with backbone atom r.m.s.d. values of 0.74 Å between PFA and the first domain (residues S2 to I132 of PFA and residues A2 to V132 of MBHA) and 0.60 Å between PFA and the second domain of MBHA (residues S2 to I132 of PFA and residues D136 to L266 of MBHA). This extensive structural similarity parallels the significant degree of amino acid identity throughout the protein sequences ( Figure 1A ). It is worth pointing out, however, that some conformational differences are observed in the loop regions connecting β1-β2, β5-β6, and β6-β7 for OAA and PFA, and the loop regions connecting β1-β2, β4-β5, β5-β6, and β6-β7 for OAA and the first barrel of MBHA, and the loop regions connecting strands β1-β2, β2-β3, β4-β5, β5-β6, β6-β7 and β7-β8 for OAA and the second barrel of MBHA (Figure 2 ). Given that the amino acids around these loops are highly conserved ( Figure 1A ) and previous relaxation studies on OAA revealed that these regions are flexible, these minor conformational differences most likely arise from differences in crystal packing among these proteins.
PFA and MBHA strongly and specifically bind to α3,α6-mannopentaose in solution -OAA's anti-HIV activity is associated with its binding to Nlinked high mannose glycans on the viral envelope glycoprotein gp120 (23, 38) . The epitope that is recognized by OAA on Man-8/9 is α3,α6- Figure 3A) . All expected amide backbone resonances are observed and complete backbone assignments for free and bound PFA were obtained from 3D HNCACB and HN(CO)CACB spectra. Similar to OAA, α3,α6-mannopentaose binding to PFA is in slow exchange on the NMR chemical shift scale, suggesting a relatively tight interaction.
Chemical shift differences between free PFA and sugar-bound resonances at saturation (protein:sugar molar ratio of 1:3) are displayed along the polypeptide chain in Figure 3B . As can be appreciated, the most strongly affected residues are located in the loops, connecting strands β1-β2 and β9-β10 (site 1 -black bars) and between strands β4-β5 and β6-β7 (site 2 -red bars), respectively. Smaller changes are seen for the loops connecting β7-β8 (site 1 -black bars) and β2-β3 (site 2 -red bars). Resonances with chemical shift differences of > 0.08 ppm (~ > 1x average value) include residues N8-S14, W17-H18, I101, N118-Y120, E123-G124, I126-G127, and G130 in the first binding site and residues M51, Y53, E56-G57, I59-G60, Q76-A82, and W84-H85 in the second binding site. These amino acids are equivalent to those in OAA that were perturbed by addition of the same sugar (24) . Therefore, the binding sites in both proteins are located in corresponding regions of the structures, consistent with the extensive sequence conservation in these sites. the two binding sites in PFA. As can be observed in the titration data, for increasing protein-α3,α6-mannopentaose molar ratios, starting with 1:0 (free protein -black), via 1:0.25 (red), 1:0.5 (green), 1:1 (blue), 1:1.5 (yellow), 1:2 (magenta), to 1:3 (cyan), the amide resonances of residues Q9 and A15 (Figure 3C ), residue I126 ( Figure 3D) , and residues G11 and G127 ( Figure 3E ) that are all located in binding site 1, are perturbed earlier than the corresponding resonances of residues in binding site 2 (residues Q76 and A82 ( Figure 3C ), residue I59 ( Figure 3D ), and residues G78 and G60 ( Figure 3E) ). However, both binding sites are completely saturated at a protein-to-α3,α6-mannopentaose molar ratio of 1:3, suggesting that the affinity for binding site 1 is ~1.5 fold tighter than that for binding site 2. This is different from our findings with OAA, where both binding sites exhibited essentially indistinguishable affinity (24) . It may be tempting to speculate that the difference in affinity is related to the slight difference in conformation, in particular considering the loop regions connecting strands β1-β2 in site 1 and β6-β7 in site 2. However, given that these loop regions are flexible in the apo form in solution and influenced by crystal packing, we cannot with any certainty draw this conclusion. We believe that it is more likely that the amino acid differences between the two sites in PFA (24 differences in 65 amino acids), compared to that in OAA (14 differences in 65 amino acids) play a role. Note that the sugar titrations for both proteins were carried out with identical protein concentrations (40 µM), using the same buffer conditions, the same stock of glycan solution, the same spectrometer, and performed on the same day. Therefore, even small differences can be reliably quantified.
We also carried out carbohydrate binding studies by NMR titration experiments for MBHA. The 2D 1 H-15 N HSQC spectra of apo (black) and α3,α6-mannopentaose-bound (magenta) MBHA are well dispersed, indicative of a well-folded structure ( Figure 4A) 
1 H-15 N HSQC spectra of the protein with increasing amounts of α3,α6-mannopentaose at molar ratios of 1:0 (free protein -black), 1:1 (red), 1:2 (green), 1:4 (blue), and 1:6 (magenta) are displayed in Figure 4 . Figure 4B ). More importantly, at a molar ratio of 1:2 (green), where each binding site should be half saturated if identical sugar affinities were present, higher intensity for bound resonances of residues A149 and A216 compared to those of A15 and A82 are observed, clearly suggesting tighter affinities for sites 3 and 4. Third, both higher affinity sites are located in the second barrel of MBHA ( Figure 1D ). Similar observations hold for the Y53, Y120, Y187, and Y254 ( Figure 4C ), S13, T80, S147, and S214 ( Figure 4D ) and G60, G127, G194, and G261 ( Figure  4E ) resonances. Resonances of Y187/Y254/G194 and S147/S214/G261 that belong to amino acids in sequence repeats 3 and 4, respectively, were affected earlier in the titration than their counterparts in sequence repeats 1 and 2.
Therefore, our data show that of the four carbohydrate binding sites in MBHA, those in the second domain bind carbohydrate more tightly than those in the first domain. This was somewhat unexpected, given the slight differences in affinity for the sites in a single barrel OAAH lectin. However, since at most a factor of 1.5-2 is observed, this variation in affinities most likely just reflects minor variations in amino acid sequence.
Structural basis for carbohydrate specificity of PFA and MBHA -Given that both, PFA and MBHA, strongly and specifically bind to α3,α6-mannopentaose, we aimed to crystallize the PFAand MBHA-α3,α6-mannopentaose complexes by soaking or co-crystallization. Our attempts to soak sugar into the apo crystals were unsuccessful, and even the addition of small amounts of glycan resulted in the immediate dissolution of the PFA or MBHA crystals. This can be explained by the tight packing of the proteins in the crystal lattice, occluding the sugar binding sites. We therefore pursued co-crystallization at protein:sugar molar ratios of 1:3 and 1:6, with protein concentrations of 40 mg/ml and 30 mg/ml for PFA and MBHA, respectively, in 400 different conditions. Crystals of α3,α6-mannopentaose-bound MBHA were obtained in 0.05 M KH 2 PO 4 and 20 % w/v polyethylene glycol 3,350. The protein crystallized in space group P2 1 2 1 2 1 , with one protein molecule per asymmetric unit. The complex structure was solved by molecular replacement using the apo structure of MBHA, comprising residues 2 to 267 as the structural probe in PHASER (28) . The final model was refined to 1.76 Å resolution with R=18.6 % and R free = 21.4 %.
Interestingly, the structure of α3,α6-mannopentaose-bound MBHA revealed that only the two higher affinity sites, i.e binding sites 3 and 4 that are both located in the second domain of MBHA, are occupied by the glycan ( Figure 5A ). Clear electron density at two opposing ends of this second barrel allowed for an excellent fit of the atomic structures of two α3,α6-mannopentaose molecules, one per site. No equivalent density was observed in the other two binding sites in the first domain. Further inspection of the complex structure in the crystal revealed that the carbohydrate binding regions in the first barrel are close to the bound α3,α6-mannopentaose from two neighboring molecules ( Figure 5B ). Indeed, one mannose unit at the end of the site 3-bound α3,α6-mannopentaose is in close contact to residues in binding site 2 of a neighboring protein molecule, while the bound sugar in site 4 reaches over to site 1 of another neighboring molecule. Therefore, adjacent protein molecules in the crystal are bridged by the glycans that simultaneously contact sites 3 and 4 and 1 and 2, respectively, facilitating crystal formation. In solution, on the other hand, we know from our NMR titration data, that sites 1 and 2 can bind α3,α6-mannopentaose similar to binding sites 3 and 4 ( Figure 4 ), albeit with slightly reduced affinity.
Not surprisingly, the structures of the apo-and α3,α6-mannopentaose-bound MBHA are very similar with backbone and heavy atom r.m.s.d. values of 0.57 and 0.93 Å, respectively ( Figure  5C ), with only a minor difference in the binding site 2 loops. Therefore, within the error of the coordinates, no significant difference in the conformation of three of the four binding sites between the free and carbohydrate-bound MBHA structure can be seen.
The structure of the MBHA-α3,α6-mannopentaose complex reveals specific contacts between MBHA side chains and the carbohydrate. As shown in Figures 5D and 5E , the aromatic side chain of W144 in site 3 and W211 in site 4 play critical roles, providing hydrophobic contacts for the pyranose ring of M3. In addition, several polar interactions are also observed. These include hydrogen bonds between the hydroxyl groups of the sugar and main chain amide groups, as well as several side chains. In binding site 3 ( Figure 5E ), hydrogen bonds are formed between the backbone amide of G145 and the C5 hydroxyl group of M5', the backbone amide of G146 and the C6 hydroxyl group of M5', and the backbone amide of G258 and the C5 hydroxyl group of M4'. Side chain interactions in binding site 3 include hydrogen bonds between the C4 hydroxyl group of M3 and by guest on September 1, 2017 http://www.jbc.org/ Downloaded from the side chain carboxyl group of E257 and between the C4 hydroxyl group of M3 and the terminal guanidinium group of R229. Equivalent hydrogen bonds are found in binding site 4 ( Figure  5E ), such as hydrogen bonds between the backbone amide of G212 and the C5 hydroxyl group of M5', the backbone amide of G213 and the C6 hydroxyl group of M5', and the backbone amide of G191 and the C5 hydroxyl group of M4', with side chain hydrogen bonding between the C4 hydroxyl group of M3 and the side chain carboxyl group of E190 and between the C4 hydroxyl group of M3 and the terminal guanidinium group of R162.
Given the high sequence conservation in the carbohydrate binding regions between MBHA and OAA ( Figure 1A) , it is not surprising that all specific contacts that are observed in the MBHA-α3,α6-mannopentaose complex are identical to those observed previously in the OAA-α3,α6-mannopentaose complex (24) .
Unlike for OAA and MBHA, we were not successful in obtaining crystals of the PFA-α3,α6-mannopentaose complex. Nevertheless, given the high amino acid conservation in the carbohydrate binding loops among PFA, OAA, and MBHA ( Figure 1A) , the chemical shift perturbation profile of PFA upon α3,α6-mannopentaose titration ( Figures 1B and 3B) , and the identical interactions observed in the complexes of MBHA-α3,α6-mannopentaose and OAA-α3,α6-mannopentaose ( Figure 5D and 5E), we are confident that a reliable model for PFA-α3,α6-mannopentaose complex can be derived. This is provided in Figure  6 , and was obtained by exchanging OAA residues in the structure of the OAA-α3,α6-mannopentaose complex to the corresponding PFA amino acids. The residue variability in the hydrophobic core of both proteins is very minor, and only six residues are different, namely I25L, V38L, L47F, L92I, I103L, and M118N ( Figure 6A ). The remaining non-identical amino acids are located on the surface of the proteins, as illustrated in Figure 6B . Interestingly, all residues that play major roles in contacting the carbohydrate in OAA and MBHA are completely conserved in PFA. These include residues W10-G12, R95, and E123-G124 in binding site 1 ( Figure 6C ) and W77-G79, R28, and E56-G57 in binding site 2 ( Figure 6D ). Between OAA and PFA, almost all residues in the carbohydrate binding sites 1 and 2, encompassing loop regions between strands β1-β2, β7-β8, and β9-β10 (site 1) and between strands β6-β7, β2-β3, and β4-β5 (site 2) are also conserved. Even though the interaction model between PFA and α3,α6-mannopentaose could potentially be validated using a docking program, our manual model provides compelling evidence that the interaction between PFA and α3,α6-mannopentaose in all likelihood is the same as in the OAA-α3,α6-mannopentaose or the MBHA-α3,α6-mannopentaose complexes.
Anti-HIV activities of PFA and MBHA -OAA's anti-HIV activity is mediated by the specific recognition of α3,α6-mannopentaose, the branched core unit of Man-8 and Man-9 (23,38), major high-mannose sugars on the HIV-1 envelope glycoprotein gp120 (39) . Here, we show that both PFA and MBHA also interact with this glycan structure, suggesting possible similar activities for these lectins. We therefore tested these molecules in HIV assays, using monomeric P51G CV-N and OAA as controls. If solely avidity considerations were significant, one would expect MBHA to exhibit higher anti-HIV activity than OAA and PFA, given that it possesses four sugar binding sites, compared to only two sites in latter lectins. We interpret the comparable activity for all OAAH family members such that only one or two binding sites can engage the sugars on gp120 and that potentially a single interaction is important for anti-HIV activity.
Importantly, CV-N is more active (~30 fold improved IC 50 value) than any of the three OAAHs. Considering that CV-N, OAA, and PFA share the same number of binding sites for carbohydrate and the dissociation constants of these lectins for the individual sugar ligands are relatively similar (in the low micromolar range) (23, 40) , one would expect comparable inhibition with similar IC 50 values. This clearly is not the case. We therefore propose the following explanation: OAA, PFA, and MBHA recognize only a single epitope of Man-8/9, namely the branched core unit (24), while CV-N binds to Manα(1-2)Man units on the D1 or D3 arms (11, 12) , i.e. interacts with two alternative epitopes on the glycan. Therefore, multi-site and multiepitope recognition seem essential for the most potent HIV inactivation (a schematic model for HIV inactivation is provided in Figure 9 ).
In addition to the native three OAAH family members, we also created a hybrid protein from OAA and PFA (named OPA), in which the two parental proteins are connected by a two-residue N-G linker between the C-terminus of OAA and the N-terminus of PFA. As shown in Figures 8A and 8B, the 2D 1 H-15 N HSQC spectrum of OPA exhibits all the characteristics of a well-folded structure and is essentially identical to the sum of the 1 H-15 N HSQC spectra of OAA ( Figure 8A green) and PFA ( Figure 8B -magenta) with only minor perturbations involving the last C-terminal residues of OAA and first N-terminal residues of PFA ( Figure 8C) . Therefore, the overall structure of OPA is essentially a tandem, double barrel protein in which OAA and PFA are linked.
Interestingly, in the HIV assays OPA inhibited HIV replication slightly better than OAA or PFA, displaying an IC 50 of 7.5 ± 0.5 nM (Figure 7 ). Although this difference is small, it was nevertheless surprising, since only very minor conformational changes from the original OAA and PFA structures were expected in the hybrid OPA. We therefore tested whether, fortuitously, the apparent glycan affinity was altered.
The data in Figure 8D shows that OPA specifically interacts with α3,α6-mannopentaose and that binding is in slow exchange on the NMR chemical shift scale. OPA's resonances were completely saturated at a protein:sugar molar ratio of 1:4 (colored in blue - Figure 8D ), indicating that the four binding sites in OPA are competent for sugar binding. For OAA, PFA, and MBHA saturation was reached at a protein:sugar molar ratio of 1:3 (24), 1:3 ( Figures 3C -3E ), and 1:6 ( Figures 4B -4E ), respectively, suggesting that each binding site in OPA exhibits a slightly higher affinity for the sugar than observed in the parental OAA and PFA lectins or the double domain MBHA protein.
In addition to the delineation of the four binding sites in OPA (see the affected resonances of A15 and A82, Figure 8E and G60 and G127, Figure  8F ) derived from OAA and PFA, respectively (colored in cyan and magenta), each binding site in OPA exhibits essentially identical affinity towards α3,α6-mannopentaose, with resonances of all interacting residues equally perturbed at the 1:2 molar ratio, where each binding site should be half saturated for identical sugar affinities ( Figure  8E and 8F -green) . This is different from PFA where slightly different affinities are observed for the two binding sites (Figures 3C -3E ). The equal affinity for each binding site in the hybrid protein, may be the result of a minor structural change caused by the linker, or a small positive avidity effect. This slightly tighter glycan binding may contribute to the somewhat higher apparent anti-HIV potency noted in the HIV assays. It is also worth pointing out that the α3,α6-mannopentaosebound resonances for equivalent residues in OPA, OAA and PFA exhibit identical frequencies (Figure 8G and 8H ; OPA, OAA, and PFA are colored blue, cyan, and magenta, respectively), suggesting very similar conformations of OPA and its parental proteins in the bound state.
CONCLUSION
Crystal structures for two members of the OAAH lectin family, PFA and MBHA, were determined at resolutions of 1.70 Å and 1.60 Å, respectively, as well as for the α3,α6-mannopentaose-bound MBHA at 1.76 Å. Structural comparison between these two new members and OAA, the founding member of the OAAH lectin family, revealed a very similar overall fold, with only minor conformational differences in the loop regions, connecting strands β1-β2, β2-β3, β4-β5, β5-β6, β6-β7 and β7-β8, that are caused by different crystal packing in these proteins. These new members bind tightly and specifically to α3,α6-mannopentaose, exhibiting identical intermolecular interactions to those previously observed in the OAA-α3,α6-mannopentaose complex structure. HIV assays revealed that all OAAH proteins and the designer hybrid OAAH (OPA) display anti-HIV activity and all are slightly less potent than CV-N. Our results provide further details towards a structural understanding of the protein-carbohydrate interaction in this novel lectin family, as well as insights into the molecular basis of its HIV inactivation properties. Such data can potentially be used in the development of lectins as antiviral reagents that target the gp120 glycans in the quest to combat HIV transmission. α3,α6-mannopentaose bound MBHA at 1:1 (red), 1:2 (green), 1:4 (blue), and at 1:6 (magenta) molar ratios of MBHA to sugar for residues A15/A82/A149/A216 (B), residues Y53/Y120/Y187/Y257 (C), residues S13/T80/S147/S214 (D), and residues G60/G127/G194/G261 (E). All spectra are plotted at the same contour level and all titrations were carried out using 0.100 mM MBHA in 20 mM NaAcetate, 20 mM NaCl, 3 mM NaN 3 Residues that are in direct contact with the carbohydrate are identical in PFA and OAA: W10, G11, G12, R95, E123, and G124 in binding site 1 (C) and W77, G78, G78, R28, E56, and G57 in binding site 2 (D). The protein is depicted in both ribbon and stick representation, with bound α3,α6-mannopentaose in stick representation only. All carbon, oxygen, and nitrogen atoms of the conserved residues in PFA and OAA and in the carbohydrates are shown in white, red, and blue, respectively. The carbon atoms of differing residues in PFA and OAA are colored in cyan. Amino acids are labeled by single-letter code and the sugar rings of the carbohydrate are labeled according to standard nomenclature. In the absence of antiviral lectins, the interaction between gp120 and CD4 introduces a conformational change that allows the fusion peptide of gp41 to penetrate the cell membrane, leading to viral-cell membrane fusion and HIV capsid deposition into the cell (A). In the presence of antiviral lectins they bind to the high-mannose glycans on gp120/41, preventing the required conformational change, thereby blocking infection (B). The glycan epitopes of Man-9 that are recognized by CV-N (highlighted in magenta) and OAA (highlighted in blue) as well as their detailed interactions at the atomic level are provided at the right hand side.
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